Summary: Postthrombotic syndrome (PTS) is the most common complication after iliofemoral deep vein thrombosis. It reduces quality of life and increases deep vein thrombosis (DVT)-related costs. The clinical symptoms and severity of PTS may vary; the most common symptoms include edema, pain (venous claudication), hyperpigmentation, lipodermatosclerosis, and ulceration. PTS is based on the principle of outfl ow obstruction, which may be caused by venous hypertension and may lead to valvular damage and venous refl ux or insuffi ciency. Recent technical developments and new stent techniques now allow recanalisation of even complex venous outfl ow obstructions within the iliac vein and the inferior vena cava. This manuscript gives an overview on the latest standards for venous recanalisation.
Introduction
Deep vein thrombosis (DVT) occurs at a rate of 1/1000 inhabitants per year in Western Europe [1] . Depending on the location and extent of DVT, 20-83 % of patients develop a postthrombotic syndrome (PTS) despite optimal anticoagulation [1, 2] . Iliac veins are involved in about 40 % of iliofemoral thromboses [3] , while standard treatment fails to achieve suffi cient recanalisation of these veins in about 70 % of cases [4] . Inadequate recanalisation of venous blood fl ow causes a persistent outfl ow obstruction with hemodynamic eff ects, inducing valve incompetence of the deep veins and subsequent valve failure of the saphenous veins of the aff ected lower extremity. The clinical symptoms include venous claudication and even venous ulcers. The general assumption that individually adjusted and systematic compression therapy can halt the disease process of a postthrombotic syndrome (PTS) was disproved recently in a randomized study [5, 6] . In order to limit clinical sequelae once PTS has been established, prompt recanalisation of a chronic venous occlusion is required.
Pathophysiology and clinical evaluation
Postthrombotic venous obstruction with increased outfl ow resistance, damaged venous valves with refl ux, and fi brotic vein walls with reduced compliance lead to venous hypertension [7, 8] .
Elevated pressure in the veins is passed on to the capillaries, which then become dilated and more permeable. This in turn leads to edema, infl ammation, and pigmentation due to hemosiderin deposits -and eventually to characteristic alterations of the skin (lipodermatosclerosis) and venous ulcers. Venous hypertension also causes distension of the deep veins and aggravates valve insuffi ciency, which is passed on to the superfi cial venous system through the perforating veins (secondary varicosity). The resulting pathophysiological changes lead to capillary leakage in microvascular blood fl ow and subsequently destroy the capillary bed, culminating in a variety of clinical symptoms including venous ulcers.
Predisposing factors for the development of a postthrombotic syndrome are:
• Persistent proximal obstruction • Axial refl ux with a refl ux volume > 5 ml/s • Combination of refl ux and obstruction • Recurrent DVT events • Advanced age • Obesity • Poor compliance with treatment
Venous compression syndromes
Proximal venous outfl ow obstruction plays an essential role in the establishment and preservation of PTS. Outfl ow obstruction is particularly related to venous compression syndromes, of which the May-Thurner syndrome -due to anatomical conditions -is best known. The proximal leftsided common iliac vein is compressed between the 5 th lumbar vertebra and the right-sided common iliac artery ( Figure 1 ). As early as in 1851, Virchow described this form of venous compression and reported that a left-sided deep leg vein thrombosis occurs about fi ve times more frequently than a right-sided one [9] . In 1957, the pathologists May and Thurner published a detailed anatomical description of this pathology [10] . Cockett and Thomas continued the analysis initiated by May and Thurner and noted an evident clinical correlation between the described venous compression and a postthrombotic syndrome [11] . Thus, the May-Thurner syndrome and the Cockett syndrome are synonymous terms for the same type of venous compression. Cadaver investigations from the above-mentioned studies and more recent publications show that a pathological compression of the left-sided common iliac vein was present in 22-32 % of the examined cadavers. Clinically, the compression syndrome may go unnoticed for several years until it becomes symptomatic, usually because of external and internal circumstances (such as trauma, confi nement to bed, or acquired diseases). One of the manifestations of this condition is an iliofemoral thrombosis. The signifi cance of venous compression in patients with an iliofemoral thrombosis was confi rmed by Oguzkurt et al. [12] in a study comprising 34 patients, who received a CT investigation for diagnostic clarifi cation of a DVT in the corresponding region. Twenty-three of the 34 patients (68 %) had a minimum 70 % stenosis of the common iliac vein in the form of a May-Thurner syndrome. The mechanical alteration of the left-sided common iliac vein, which persists for several years, may then cause a marked thickening of the vessel wall, stenoses, scars, a local thrombus, or septation in the respective segment of the vein. Symptomatic patients frequently reveal unilateral swelling of the leg, pain in the groin, venous claudication, or a secondary chronic venous insuffi ciency.
In addition to venous compression syndromes due to anatomical conditions, there may be other reasons for an acute or chronic venous outfl ow obstruction: 
Clinical evaluation of venous disease and indication for recanalisation
Patients with clinical symptoms in accordance with the CEAP classifi cation 3-6 should be scheduled for revascularisation therapy when the clinician fi nds evidence of an iliac vein obstruction aff ecting the patient's hemodynamic condition. In addition to the CEAP classifi cation, currently the rVCSS score, the CIVIQ-20 score, the VEINES-QoL score, and the Villalta score permit a much better classifi cation of objective and subjective venous symptoms in the presence of chronic venous disease (a summary of the above-mentioned classifi cations and scores is available at http://www.veinforum.org/medical-and-allied-health-professionals/avf-initiatives/ceap-and-venous-severity-scoring/venous-severity-scoring). These validated and established scores should be used as standard procedures when following patients after surgery in order to assess their clini-
Recommendation
In patients with clinical signs of venous hypertension of the leg, the clinician should rule out a venous outfl ow obstruction. • Digital subtraction angiography (see below)
• Intravascular ultrasound (see below; the anticipated gold standard for invasive diagnostic investigation)
Doppler and duplex investigation
Doppler and duplex venous imaging is the imaging modality of choice in the diagnostic workfl ow for suspected venous outfl ow obstruction and refl ux. It provides information about the underlying pathology and the anatomic extent of disease, but can be diffi cult to interpret in the iliac veins, especially in obese patients. However, pathologic venous Doppler examination can demand additional radiologic pelvic imaging to obtain information about the extent of the disease and also to exclude extravascular diseasecausing venous outfl ow obstruction (Figures 3a and 3b ).
Radiological diagnostic investigation CT and MR venography
Non-invasive imaging prior to intervention is extremely helpful to underpin the clinical diagnosis and to plan the procedure. The modality of choice is characterised by high reproducibility, sensitivity, and specifi city. Iliocaval obstructions and the accompanying pathological changes can be visualised by MR venography (MR-V) as well as CT venography (CT-V) [13, 14] . For example, both procedures can detect, with certainty, underlying compression pathologies such as the May-Thurner syndrome. Because such a hemodynamically signifi cant iliac obstruction is present in cal progress. One limitation of the scores is that they do not register whether a patient has a venous claudication, which has a major impact on physical capacity, especially in young patients. In terms of clinical appearance, venous claudication does not diff er from pain due to arterial causes. The duration of pain is usually longer after a stress phase and is an expression of high venous pressure in the lower leg under stress. A phlebodynamometry is performed to obtain objective evidence of elevated venous pressure; it should be preceded by a standard treadmill test (12 % elevation, 3 km/h) and a venous occlusion plethysmography.
Venous claudication is an indication for pelvic vein recanalisation.
A standardised stepwise diagnostic scheme was not established in the published literature. However, according to expert opinion the scheme could be as follows ( should be taken to ensure adequate fi lling with a high-molecular-weight contrast medium through an adequately large catheter lumen (8-10 F) . Further, a DSA should be performed in the presence of an induced respiratory standstill. A bladder catheter inserted prior to the investigation or the recanalisation procedure prevents concealment of venous blood fl ow in pelvic veins due to a bladder fi lled with contrast medium; this is especially true of angulated images. Abscessed (lumbar) venous collaterals, collaterals of the internal iliac region to the contralateral pelvic vein (presacral) as well as the visualisation of a spontaneous suprapubic collateral (natural Palma) are urgent signs of a pelvic venous congestion with hemodynamic eff ects.
Intravascular ultrasound (IVUS)
Compared to a standard DSA for the evaluation of a venous congestion or lesion, IVUS off ers the option of detecting a reduction in diameter as well as the much more signifi cant reduction of area. Standardised use of IVUS about 80 % of iliofemoral thromboses, MR-V or CT-V should be performed for diagnostic purposes prior to invasive treatment (especially in young patients) [12, 15, 16] . A recommendation of CT-V over MR-V remains diffi cult. Availability, scanning time, radiation exposure, iodinated contrast, and personal expertise all are important aspects to consider. Because the majority of patients with acute or chronic iliofemoral venous obstructions are relatively young females, limiting radiation exposure should be of high priority. Further, determining the (endovascular) options in patients with extensive postthrombotic obstruction by evaluating the common femoral vein is crucial. Preinterventional imaging should be effi cient to exclude acute or chronic obstruction of the (deep) femoral veins hampering infl ow. Although no comparative studies are available on the sensitivity of MR-V or CT-V for subtle postthrombotic trabeculations, intrinsic technical qualities seem to favor MR-V. Finally, MR-V may be helpful to predict the success of thrombolysis/ thrombectomy by estimation of thrombus age.
In conclusion, in light of the superior diagnostic potential and safety profi le, MR-V is the imaging modality of choice prior to deep venous intervention.
DSA phlebography
A DSA may not be adequate for an accurate diameter analysis of a pelvic vein or a venous obstruction. The impact of vessel diameter, various degrees of venous fi lling, breathmodulated diameters, and the structure of the vein wall are responsible for the elliptical shape of iliac veins. Because of this shape, it may be diffi cult to identify a lesion or quantify a stenosis, so that, in the presence of a parallel axis of the lesion and with a set angiography angle, even a high-grade stenosis may escape detection. Therefore, in addition to an anteroposterior image, one should obtain at least two angulated projections (90 degrees LAO and RAO). Care 
Technical details of recanalisation
Venous dilatation and stenting is painful and in some patients may take a considerable amount of time. Doing the intervention under local anesthesia should be confi ned to patients with circumscribed stenoses in the iliac region, such as those with the May-Thurner syndrome. General anesthesia or monitored conscious sedation is preferred in all other cases. The femoral vein is a suitable access for iliofemoral and caval recanalisation. The popliteal vein, the right-sided internal jugular vein, and the contralateral common femoral vein may also be used. As a last resort, one may use the large saphenous vein or the deep femoral vein as the path of access.
The vein is punctured under ultrasound guidance. After introducing a sheath by Seldinger technique, a variety of wires or catheters may be used to pass through the stenosis. Once the wire has been introduced, the constriction or obstruction is dilated with a large-lumen balloon catheter. The vein should be predilated at least to the diameter and length of the stent to be inserted. Implantation of a venous stent is followed by postdilatation. The stent PTA procedure (Figures 3a and 3b) should be performed from one healthy segment to another healthy segment. In other words, PTA stenting covers the entire postthrombotic venous segment. A constriction in the common iliac vein should always be overstented. A control phlebography in two planes is mandatory. Successful recanalisation is followed by rapid outfl ow of contrast medium over the entire stented iliac fl ow region. Collaterals should no longer be seen [19] .
Early thrombotic occlusions are nearly always unavoidable despite successful iliac stent PTA when there is no suffi cient infl ux from the femoral veins and/or the large saphenous vein. In cases involving the common femoral vein, which is a sign of limited infl ux, it may be necessary to insert an arteriovenous (AV) fi stula. This is performed either as a hybrid procedure during endovascular revascularisation or immediately thereafter.
Technical tips and tricks for recanalisation:
• Ultrasound-guided puncture • Ipsilateral puncture is always better than the contralateral approach
• DSA in several angulated projections for the analysis of stenoses and obstructions
• Recanalisation of the chronic obstruction using a rigid 0.035-inch guidewire with a hydrophilic coating
• A supporting catheter may be needed for recanalisation in cases of chronic obstructions permitted a much more accurate analysis of lesions (avoided false negative fi ndings) and, in particular, oversizing the stent. A standard IVUS performed on a routine basis after stent implantation much more frequently revealed a residual stenosis that could then be dilated (Figure 3 ). The recently published VIDIO (venography versus intravascular ultrasound for diagnosis of iliofemoral vein occlusive disease) study [17, 18] was a prospective multicenter investigation that clearly showed the advantages of diagnostic IVUS investigation over standard venography. A group of 100 patients with an iliac outfl ow obstruction underwent standard angiographies (anteroposterior, RAO 30 degrees, LAO 30 degrees). Based on this angiographic investigation, the examiners had to establish whether the patient had a venous stenosis aff ecting the patient's hemodynamic condition. The investigation was substantiated with an IVUS analysis, followed by a renewed assessment. In all a total of 300 vein segments were analysed. IVUS revealed a signifi cant stenosis in 63 segments (21 %) that were not identifi ed on venography. Furthermore, the grade of stenosis on IVUS was 11 % higher than that on the corresponding venography. Based on the IVUS analysis, the treatment plan was modifi ed in 60 of 100 patients, and a stent implantation was performed.
This study is of enormous signifi cance with regard to the quality requirements for venous interventions.
A sobering fact, however, is that the technical eff ort has not yet been mentioned in the current DRG system for 2017; the procedure involves substantial additional costs for the intervention centers. 
Advantages of IVUS
•
Recommendation
Hybrid procedures with simultaneous endophlebectomy and/or the insertion of an AV fi stula are recommended in cases of insuffi cient infl ux from the femoral vein. [21] . Stuck and colleagues evaluated the sinusObliquus stent in 20 patients with chronic and acute VOO, and found a primary patency rate of 92 % at 6 months and 83 % at 10 months [22] . The Zilver® Vena™ stent was shown by O'Sullivan et al. [23] to have a socalled "clinical" patency rate of 85 % at a short-median follow-up of 55 days. This cohort included patients with acute ilio-femoral thrombosis (70 %), and half of the patients had advanced malignancy.
No direct comparison exists between stents of diff erent designs. It is diffi cult to compare stent patency rates from the various reports, because the patency rates are highly infl uenced by the aetiology and severity of the disease. Extensive postthrombotic occlusive disease with poor infl ow to the stent system do worse than focal nonthrombotic iliac vein lesions. Therefore, it is important to know what type of patients are included in the studies reporting stent patency rates. Venous stent patency rates are markedly diff erent in PTO and NIVL patients. In a study by Neglen et al. [24] , primary, assisted-primary, and secondary cumulative patency rates in 303 patients with PTO and 302 patients with NIVL patients were 79 %, 100 %, and 100 %, and 57 %, 80 %, and 86 % at 72 months, respectively. That study used Wallstents® exclusively. A recent meta-analysis by Razavi et al. of 1,122 patients with NIVL and 1,118 patients with PTO showed a primary patency rate at 12 months of 96 % and 79 %, respectively [25] . Wallstents® were used in 78 % of studies analysed. The cumulative primary and secondary patency rates remained higher in nonthrombotic patients than in the postthrombotic patients throughout 5 years (primary patency at 5 years approximately 90 % and 65 %, respectively).
Anticoagulation
Anticoagulant therapy started during the intervention is continued after the intervention, usually for 3 to 6 months. When using vitamin K antagonists for anticoagulation, the clinician should aim to achieve a target INR value of 2.5 to 3.5 (Table 1) . When the value drops below the minimum, it is advisable to additionally administer low-mo-A transjugular access is usually needed for recanalisation in obstructions of the inferior vena cava
Novel venous stents
Initially it was common practice to use arterial PTA stents (such as Wallstents or nitinol stents) for recanalising blood fl ow in the iliac veins. However, PTA stenting of a postthrombotic vein with intraluminal scarring -and frequently also with external compression -is not similar to an arterial PTA stenting in the presence of arteriosclerosis. Stents for venous recanalisation must fulfi l their own standards. Therefore, special stents were developed for interventions in the iliac veins (Figure 5a, 5b and 6 can be aligned to the anatomical course of the veins even during movement -and not vice versa. Angulation is highest (ranging up to 90°) in the sitting position, especially in the iliac confl uence, at the junction between the external iliac vein and the common iliac vein.
In summary, stents approved for the venous system are very fl exible and possess a high degree of radial force. There are currently six dedicated venous stents on the market in Europe: The sinus-Venous and sinus-Obliquus
Recommendation
Only approved vein stents should be used for venous recanalisation because only these fulfi l the functional requirements of the procedure. 
